Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD)
Clinical trial NCT01983241 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01983241
- Sponsor
- Grifols Therapeutics LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2026-08-01
- Enrollment
- 345
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.